Growth Metrics

Vericel (VCEL) EPS (Basic) (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Vericel 1.69 Bn 1.55 Bn 49.27 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -126.09%
Dec 31, 2025 360.00%
Sep 30, 2025 1,100.00%
Jun 30, 2025 95.65%
Mar 31, 2025 -157.50%
Dec 31, 2024 2,100.00%
Sep 30, 2024 80.00%
Jun 30, 2024 -25.00%
Mar 31, 2024 -129.63%
Dec 31, 2023 437.50%
Sep 30, 2023 27.27%
Jun 30, 2023 31.25%
Mar 31, 2023 -223.08%
Dec 31, 2022 192.86%
Sep 30, 2022 26.32%
Jun 30, 2022 -26.67%
Mar 31, 2022 -250.00%
Dec 31, 2021 190.91%
Sep 30, 2021 -37.50%
Jun 30, 2021 -14.29%
Mar 31, 2021 -125.93%
Dec 31, 2020 237.50%
Sep 30, 2020 144.44%
Jun 30, 2020 -80.00%
Mar 31, 2020 -147.62%
Dec 31, 2019 162.50%
Sep 30, 2019 117.78%
Jun 30, 2019 -542.86%
Mar 31, 2019 -158.33%
Dec 31, 2018 700.00%
Sep 30, 2018 83.33%
Jun 30, 2018 42.86%
Mar 31, 2018 -2,200.00%
Dec 31, 2017 106.25%
Sep 30, 2017 -128.57%
Jun 30, 2017 77.42%
Mar 31, 2017 -3,200.00%
Dec 31, 2016 102.63%
Sep 30, 2016 -72.73%
Jun 30, 2016 8.33%
Mar 31, 2016 14.29%
Dec 31, 2015 -7.69%
Sep 30, 2015 -62.50%
Jun 30, 2015 40.74%
Mar 31, 2015 -58.82%
Dec 31, 2014 79.27%
Sep 30, 2014 12.77%
Jun 30, 2014 25.40%
Mar 31, 2014 -260.00%
Dec 31, 2013 70.83%
Sep 30, 2013 55.88%
Jun 30, 2013 9.33%
Mar 31, 2013 -1,566.67%
Dec 31, 2012 -5.88%
Sep 30, 2012 22.73%
Jun 30, 2012 12.00%
Mar 31, 2012 -257.14%
Dec 31, 2011 -40.00%
Sep 30, 2010 -61.54%